NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 232 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $914,000 | +10.4% | 5,516 | -7.0% | 0.00% | 0.0% |
| Q1 2021 | $828,000 | -11.8% | 5,934 | +9.4% | 0.00% | 0.0% |
| Q4 2020 | $939,000 | +129.6% | 5,423 | +84.8% | 0.00% | 0.0% |
| Q3 2020 | $409,000 | +16.9% | 2,935 | +0.1% | 0.00% | – |
| Q2 2020 | $350,000 | +57.0% | 2,932 | -24.9% | 0.00% | – |
| Q3 2018 | $223,000 | -36.5% | 3,906 | -11.2% | 0.00% | -100.0% |
| Q2 2018 | $351,000 | -8.4% | 4,397 | -0.5% | 0.00% | 0.0% |
| Q1 2018 | $383,000 | -81.2% | 4,418 | -85.0% | 0.00% | -75.0% |
| Q4 2017 | $2,040,000 | -28.2% | 29,550 | -5.4% | 0.00% | -33.3% |
| Q3 2017 | $2,840,000 | +9.1% | 31,245 | -10.7% | 0.01% | 0.0% |
| Q2 2017 | $2,603,000 | +0.9% | 34,976 | +27.0% | 0.01% | 0.0% |
| Q1 2017 | $2,581,000 | +22.0% | 27,545 | -5.4% | 0.01% | +20.0% |
| Q4 2016 | $2,116,000 | -29.6% | 29,118 | +1.2% | 0.01% | -37.5% |
| Q3 2016 | $3,004,000 | +42.4% | 28,780 | +0.6% | 0.01% | +14.3% |
| Q2 2016 | $2,110,000 | – | 28,605 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
| Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
| Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
| Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
| BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
| ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
| ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
| Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
| Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
| Olympiad Research LP | 25,046 | $210,887 | 0.16% |